LY2835219 50mg

LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity.

Price Not Available 50mg LY2835219 50mg Supplier Page

Trivial name	LY2835219 50mg
Catalog Number	A12989-50
Alternative Name(s)	2-Pyrimidinamine, N-[5-[(4-ethyl-1-piperazinyl)methyl]-2-pyridinyl]-5-fluoro-4-[4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl]
Molecular Formula	C27H32F2N8
CAS#	1231929-97-7
SMILES	CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F
Size	50mg
Supplier Page	http://www.adooq.com/ly2835219.html